Literature DB >> 12707364

Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis.

Ram Raj Singh1, Vijay Saxena, Song Zang, Lily Li, Fred D Finkelman, David P Witte, Chaim O Jacob.   

Abstract

Mechanisms that initiate lupus nephritis and cause progression to end-stage renal disease remain poorly understood. In this study, we show that lupus-prone New Zealand Mixed 2410 mice that develop a severe glomerulosclerosis and rapidly progressive renal disease overexpress IL-4 in vivo. In these mice, STAT6 deficiency or anti-IL-4 Ab treatment decreases type 2 cytokine responses and ameliorates kidney disease, particularly glomerulosclerosis, despite the presence of high levels of IgG anti-dsDNA Abs. STAT4 deficiency, however, decreases type 1 and increases type 2 cytokine responses, and accelerates nephritis, in the absence of high levels of IgG anti-dsDNA Abs. Thus, STAT6 and IL-4 may selectively contribute to the development of glomerulosclerosis, whereas STAT4 may play a role in autoantibody production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707364      PMCID: PMC2291553          DOI: 10.4049/jimmunol.170.9.4818

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

Review 1.  Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment.

Authors:  P J Sime; K M O'Reilly
Journal:  Clin Immunol       Date:  2001-06       Impact factor: 3.969

2.  The increased interleukin-13 in patients with systemic lupus erythematosus: relations to other Th1-, Th2-related cytokines and clinical findings.

Authors:  S Morimoto; Y Tokano; H Kaneko; K Nozawa; H Amano; H Hashimoto
Journal:  Autoimmunity       Date:  2001       Impact factor: 2.815

Review 3.  The role of helper T cell products in mouse B cell differentiation and isotype regulation.

Authors:  R L Coffman; B W Seymour; D A Lebman; D D Hiraki; J A Christiansen; B Shrader; H M Cherwinski; H F Savelkoul; F D Finkelman; M W Bond
Journal:  Immunol Rev       Date:  1988-02       Impact factor: 12.988

Review 4.  Delineating the genetic basis of systemic lupus erythematosus.

Authors:  E K Wakeland; K Liu; R R Graham; T W Behrens
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

5.  The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma.

Authors:  A Richter; S M Puddicombe; J L Lordan; F Bucchieri; S J Wilson; R Djukanovic; G Dent; S T Holgate; D E Davies
Journal:  Am J Respir Cell Mol Biol       Date:  2001-09       Impact factor: 6.914

6.  Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures. Potential role in fibrosis.

Authors:  P Gillery; C Fertin; J F Nicolas; F Chastang; B Kalis; J Banchereau; F X Maquart
Journal:  FEBS Lett       Date:  1992-05-18       Impact factor: 4.124

7.  Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes.

Authors:  T McGaha; S Saito; R G Phelps; R Gordon; N Noben-Trauth; W E Paul; C Bona
Journal:  J Invest Dermatol       Date:  2001-01       Impact factor: 8.551

8.  Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).

Authors:  C G Lee; R J Homer; Z Zhu; S Lanone; X Wang; V Koteliansky; J M Shipley; P Gotwals; P Noble; Q Chen; R M Senior; J A Elias
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

9.  Differential regulation of IgG1 and IgE synthesis by interleukin 4.

Authors:  C M Snapper; F D Finkelman; W E Paul
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

10.  Vaccination with minigenes encoding V(H)-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus.

Authors:  Guo-Chang Fan; Ram Raj Singh
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  57 in total

1.  Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice.

Authors:  Julia Menke; Tillmann Bork; Birte Kutska; Katelyn T Byrne; Michaela Blanfeld; Manfred Relle; Vicki R Kelley; Andreas Schwarting
Journal:  Kidney Int       Date:  2010-10-27       Impact factor: 10.612

2.  Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis.

Authors:  Celine C Berthier; Ramalingam Bethunaickan; Tania Gonzalez-Rivera; Viji Nair; Meera Ramanujam; Weijia Zhang; Erwin P Bottinger; Stephan Segerer; Maja Lindenmeyer; Clemens D Cohen; Anne Davidson; Matthias Kretzler
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

Review 3.  SLE: translating lessons from model systems to human disease.

Authors:  Ram Raj Singh
Journal:  Trends Immunol       Date:  2005-09-09       Impact factor: 16.687

4.  The histone peptide H4 71-94 alone is more effective than a cocktail of peptide epitopes in controlling lupus: immunoregulatory mechanisms.

Authors:  Hee-Kap Kang; Ming-Yi Chiang; Michael Liu; Diane Ecklund; Syamal K Datta
Journal:  J Clin Immunol       Date:  2011-02-03       Impact factor: 8.317

5.  Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease.

Authors:  Rama Devi Mittal; Parmeet Kaur Manchanda
Journal:  Immunogenetics       Date:  2007-01-04       Impact factor: 2.846

Review 6.  Role of T cells and dendritic cells in glomerular immunopathology.

Authors:  Christian Kurts; Felix Heymann; Veronika Lukacs-Kornek; Peter Boor; Jürgen Floege
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

7.  Suppression of systemic autoimmunity by the innate immune adaptor STING.

Authors:  Shruti Sharma; Allison M Campbell; Jennie Chan; Stefan A Schattgen; Gregory M Orlowski; Ribhu Nayar; Annie H Huyler; Kerstin Nündel; Chandra Mohan; Leslie J Berg; Mark J Shlomchik; Ann Marshak-Rothstein; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

8.  IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.

Authors:  Cuong Q Nguyen; Jue-hua Gao; Hyuna Kim; Daniel R Saban; Janet G Cornelius; Ammon B Peck
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

Review 9.  Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.

Authors:  Noam Jacob; William Stohl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

10.  Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells.

Authors:  Hee-Kap Kang; Diane Ecklund; Michael Liu; Syamal K Datta
Journal:  Arthritis Res Ther       Date:  2009-04-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.